Indian AI drug discovery company wins $1 million for rare disease research
Peptris Technologies, based in Bangalore, India, received $1 million in pre-seed funding in a round led by Speciale Investments.
The AI-driven drug discovery company said in a statement that it will use the new funding to expand its research to cover rare diseases, adding to existing research in cancer and inflammation.
Cipla raises stake in digital pharma solutions provider GoApptiv
Indian pharmaceutical giant Cipla has increased its stake in GoApptiv by 420 million rupees ($5 million) to 22.99%.
As part of our efforts to penetrate and provide healthcare services to underserved communities across India, we have further invested in the company, which develops end-to-end digital solutions for pharmaceutical companies.p Improve access to medicines.
Canadian insurance tech company Lydia AI targets South Korea
Lydia AI, a Canadian-based health insurance AI company, recently entered into a technology integration partnership in South Korea.
We have officially entered into an ongoing cooperation relationship with Hecto Data. They are piloting a smart data ecosystem within insurance company MetLife Korea’s 360Health application.
The Canadian insurtech company has entered into a new partnership with Tobecon to integrate predictive AI capabilities into insurance software.
Ubie to launch Android version of AI symptom checker app in the US
Japanese startup Ubie is preparing to launch an Android version of its AI-powered symptom checker app in the United States.
This mobile symptom checker, recently recognized for its AI capabilities at Google Play’s Best of 2023 Awards, helps users identify their symptoms and connects them with the right healthcare provider. Since 2020, it has now been used over 100 million times. So far he has been used more than 2 million times since it was launched in the US last year.